Choosing Cancer Weapons With the Best Aim
In oncology, we do the best we can. We give drugs with 10-20% chances of working because we have nothing …
#Market Research
Wielding New Cancer Weapons Forged in Cell-Free DNA: A Wake Up Call For The Entire Biotech Industry
Advances in computational biology, precision medicine, artificial intelligence/machine learning, etc., are launching us into a world where strategic control points …
Hunting Cancer Before It Can Hunt You: A Bird's Eye View of Cell-Free DNA Market Trends
Chapter 2 of a Hitchhiker's Guide to Cell-Free DNA. By the end of 2022, there will be an estimated 609,360 …
How Pharmaceutical Industry Is Adopting Artificial Intelligence To Boost Drug Research
What is “artificial intelligence”? Artificial intelligence (AI) is an interdisciplinary science concerned with building “intelligent agents”, the field which takes …
Big Investments for Human Microbiome Research
Major companies on the scene include Second Genome, Enterome, and EpiBiome. In addition, several new startups have entered the field. …
Pharmaceutical Giants Are Chasing R&D Deals With Smaller AI Startups
The first month of 2019 is not over yet, but there are already four major announcements about new research projects …
